Cargando…
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
Anti-transcriptional intermediary factor 1γ (anti-TIF1γ) antibody-positive dermatomyositis (DM) is strongly associated with cancer, although the mechanism of action is still unclear. We herein describe the first known case of an 80-year-old woman diagnosed with TIF1γ-positive primary pulmonary lymph...
Autores principales: | Nakanishi, Yu, Yamaguchi, Kakuhiro, Yoshida, Yusuke, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Nakashima, Taku, Miyamoto, Shintarou, Iwamoto, Hiroshi, Hirata, Shintaro, Fujitaka, Kazunori, Hamada, Hironobu, Sugiyama, Eiji, Hattori, Noboru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662058/ https://www.ncbi.nlm.nih.gov/pubmed/32581161 http://dx.doi.org/10.2169/internalmedicine.4702-20 |
Ejemplares similares
-
1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019) -
Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022) -
Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021) -
Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022) -
Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
por: Wu, Chih-Feng, et al.
Publicado: (2023)